Phase <scp>I</scp> / <scp>II</scp> Trial of the <scp>FLT3</scp> Kinase Inhibitor <scp>XY0206</scp> in Patients With Relapsed/Refractory Acute Myeloid Leukemia
R/R AML patients, supporting its further clinical development. Trial Registration: CTR20201214 (CDE); ClinicalTrials.gov ID: NCT04471064.
Authors
- Anyou Wang (ORCID: https://orcid.org/0000-0002-4981-3606)
- Junyuan Qi (ORCID: https://orcid.org/0009-0007-8321-8863)
- F Li
- Xi Zhang (ORCID: https://orcid.org/0000-0002-4638-3997)
- Qunyi Guo
- Daozi Jiang
- Xiangmin Tong (ORCID: https://orcid.org/0000-0001-5153-3753)
- Y I X I U Liang
- Jianmin Wang
- Zhongxing Jiang
- Lin Song
- Xudong Wei
- Jianxiang Wang
- Hongmei Jing (ORCID: https://orcid.org/0000-0003-4958-2489)
- Zhimin Zhai
- Yajing Xu
Institutions
- Hebei Medical University (CN)
- University of Science and Technology of China (CN)
- Central South University (CN)
- Nanchang University (CN)
- Sun Yat-sen University (CN)
- Anhui Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Wenzhou Medical University (CN)
- Wuhan University (CN)
- Zhengzhou University (CN)
- Second Hospital of Hebei Medical University (CN)
- Renmin Hospital of Wuhan University (CN)
- Peking University Third Hospital (CN)
- Henan Cancer Hospital (CN)
- Shijiazhuang Yiling Pharmaceutical (China) (CN)
- Sun Yat-sen University Cancer Center (CN)
- Institute of Hematology & Blood Diseases Hospital (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Zhejiang Taizhou Hospital (CN)
- Xiangya Hospital Central South University (CN)
- First Affiliated Hospital of Nanchang University (CN)
- State Key Laboratory of Oncology in South China
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2026-04-21
- DOI
- https://doi.org/10.1111/ejh.70164
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00